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In section "3.4.1 Time to event," first paragraph, second sentence, the median days CHF occurred without ATE in 90 cats is incorrect. The median days are 857, not 57. Second sentence should read as follows.

"In HCM: CHF occurred without ATE in 90 cats (median, 857 days; range, 2‐2954 days); ATE occurred without CHF in 25 cats (median, 370 days; range, 5‐3993 days); and, both CHF and ATE occurred in 16 cats (concurrently in 10 cats \[median, 513 days; range, 4--3353\]; ATE preceded CHF in 3 \[1775, 2384, and 3334 days\]; and CHF preceded ATE in 3 \[1178, 1316, and 2409 days\])."

In section "3.3 Survival analyses‐mortality," first paragraph, fourth sentence, a number was omitted from the upper survival range. The correct range is 3 days‐13.1 years.

The related survival range in Figure 5 was transcribed incorrectly. The correct survival range is 3 days‐13.1 years. The corrected Figure 5 is shown below.
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